OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11302	Companies
251207	Keywords
180266	Articles
137070	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 06/12/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt aangepaste transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aankoop en verkoop van aandelen en stemrechtverlenende effecten volgens Belgische transparantiewetgeving

Transparantiekennisgevingen Aandelen Oxurion NV Belgische Transparantiewetgeving Atlas Special Opportunities II LLC
BRIEF

published on 06/12/2025 at 08:35, 1 year 4 months ago

Oxurion progresse dans son acquisition d'Axiodis

Acquisition Sciences De La Vie Oxurion Axiodis FDI France
BRIEF

published on 06/12/2025 at 08:35, 1 year 4 months ago

Oxurion progresses in its acquisition of Axiodis

Acquisition Life Sciences Oxurion Axiodis FDI France
PRESS RELEASE

published on 06/12/2025 at 08:30, 1 year 4 months ago

Oxurion avance dans l'acquisition projetée d'Axiodis
Oxurion NV lève la condition suspensive relative au droit d'information préalable des salariés, avançant vers l'acquisition d'Axiodis CRO. Discussions en cours pour créer des synergies stratégiques. Oxurion se concentre sur la finalisation de l'opération

Acquisition Biopharmaceutique Donnée Clinique Oxurion NV Synergies Stratégiques
PRESS RELEASE

published on 06/12/2025 at 08:30, 1 year 4 months ago

Oxurion moves forward with the planned acquisition of Axiodis
Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO

Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
PRESS RELEASE

published on 06/12/2025 at 08:30, 1 year 4 months ago

Oxurion boekt vooruitgang met de voorgenomen overname van Axiodis
Oxurion NV meldet die Erfüllung der aufschiebenden Bedingung hinsichtlich des Informations- und Konsultationsrechts der Arbeitnehmer für die Übernahme von Axiodis CRO. Oxurion konzentriert sich auf die Fertigstellung der Transaktion und beschleunigt Gespräche mit anderen strategischen Zielen zur Schaffung von Synergien in der Region Toulouse

Übernahme Toulouse Oxurion NV Synergien Axiodis CRO
BRIEF

published on 06/11/2025 at 18:05, 1 year 4 months ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF

published on 06/11/2025 at 18:05, 1 year 4 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/11/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen met betrekking tot aankoop en verkoop van aandelen. Biofarmaceutisch bedrijf in Leuven, België. Meer informatie op www.oxurion.com

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Aankoop Aandelen Verkoop Aandelen
PRESS RELEASE

published on 06/11/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages

Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC

Accesswire

Published on 11/10/2026 at 08:00, 41 minutes ago

PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 5 hours 56 minutes ago

Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 9 hours 31 minutes ago

Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 9 hours 41 minutes ago

LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 10 hours 9 minutes ago

Announces Extension for Closing of Private Placement of Convertible Promissory Notes

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 08:30, 11 minutes ago

Restoration - Notting Hill Genesis
Published on 11/10/2026 at 08:25, 15 minutes ago

ZPMC-Led Smart Port Machinery Alliance Reports Growing Industry Collaboration at Annual Meeting
Published on 11/10/2026 at 08:15, 25 minutes ago

EOS Holding - Gen Z and millennials: tech-savvy, financially under pressure
Published on 11/10/2026 at 08:10, 30 minutes ago

ANTHBOT Announces $250 / €250 Black Friday Discounts on M5 and M9 Robotic Lawn Mowers
Published on 11/10/2026 at 08:10, 30 minutes ago

Quantinuum and RIKEN Expand Partnership to Accelerate the Commercialization of Quantum-AI Hybrid Supercomputing in Japan

Les Echos

Published on 11/10/2026 at 07:00, 1 hour 41 minutes ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 1 hour 41 minutes ago

bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 14 hours 11 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 14 hours 11 minutes ago

Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 14 hours 56 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE